Studies of Vitamin D supplements on Calcium Metabolism in Sarcoidosis
A one year randomised, double-blind placebo-controlled trial to evaluate the effects of vitamin D supplementation on serum calcium, urine calcium, bone turnover and bone density in subjects with sarcoidosis and vitamin D insufficiency.
Dr Mark Bolland
50 participants
Oct 4, 2007
Interventional
Conditions
Summary
This is a one year study designed to test whether vitamin D supplementation is safe and efficacious for patients with sarcoidosis and low vitamin D levels
Eligibility
Inclusion Criteria1
- Diagnosis of sarcoidosis
Exclusion Criteria1
- Serum creatinine >0.15 mmol/L, nephrocalcinosis, hypercalcaemia (adjusted serum calcium >2.55 mmol/L), concurrent major systemic illness (except for sarcoidosis) including malignancy, established osteoporosis (Bone mineral density T score < -2.5 and a fragility fracture)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Weekly oral calciferol 50,000 International Units (IU) for four weeks, then monthly oral calciferol 50,000 International Units (IU) for 11 months.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12607000364471